A randomized, single-dose, pharmacokinetic equivalence study comparing MB02 (proposed biosimilar) and reference bevacizumab in healthy Japanese male volunteers

被引：0
作者：
Takashi Eto
Yuji Karasuyama
Verónica González
Ana Del Campo García
机构：
[1] Souseikai Hakata Clinic,Clinical Research Unit
[2] Syneos Health Clinical K.K.,Medical Department
[3] mAbxience Research S.L.,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2021年 / 88卷
关键词：
MB02; Bevacizumab; Biosimilars; Pharmacokinetics; Safety; Japanese;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：713 / 722
页数：9
相关论文
共 50 条
  • [21] A randomized, double-blind, single-dose, two-arm, parallel study comparing pharmacokinetics, immunogenicity and tolerability of branded adalimumab and its biosimilar LBAL in healthy male volunteers
    Park, Kyoung Ryun
    Chung, Hyewon
    Yang, Sung Mo
    Lee, SeungHwan
    Yoon, Seo Hyun
    Cho, Joo-Youn
    Jang, In-Jin
    Yu, Kyung-Sang
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (05) : 619 - 624
  • [22] A Randomized, Double-Blind, Single-Dose Study Comparing the Biosimilarity of HOT-1010 With Bevacizumab (Avastin®) in Chinese Healthy Male Subjects
    Huang, Kai
    Que, Linling
    Ding, Ying
    Chu, Nannan
    Qian, Zhenzhong
    Shi, Yunfei
    Qin, Wei
    Li, Zhenni
    Chen, Yuanxin
    Gu, Xianghong
    Wang, Jiakun
    Zhang, Lin
    Zhang, Jisheng
    Zhu, Xiangyang
    Yang, Yongmin
    Tang, Yuan
    He, Qing
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [23] A phase I pharmacokinetics study comparing PF-06439535 (a potential biosimilar) with bevacizumab in healthy male volunteers
    Knight, Beverly
    Rassam, Danielle
    Liao, Shanmei
    Ewesuedo, Reginald
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (04) : 839 - 846
  • [24] A randomized, double-blind, single-dose study to evaluate the biosimilarity of QL1101 with bevacizumab in healthy male subjects
    Ya-nan Liu
    Jie Huang
    Can Guo
    Shuang Yang
    Ling Ye
    Shu-ting Wu
    Xing-fei Zhang
    Xiao-yan Yang
    Cui-cui Han
    Qi Pei
    Lu Huang
    Qing-nan He
    Guo-ping Yang
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 555 - 562
  • [25] A randomized Phase I pharmacokinetic trial comparing the potential biosimilar trastuzumab (SIBP-01) with the reference product (Herceptin®) in healthy Chinese male volunteers
    Zhou, Huan
    Cao, Shugang
    Zhu, Xingyu
    Xie, Jing
    Fan, Ling
    Ge, Qin
    Wang, Ying
    Zhu, Juan
    Liu, Yuanyuan
    Shao, ZhongHuan
    Shan, Rongfang
    Liu, Bingyan
    Wang, Hongju
    Ding, Li
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (10) : 997 - 1003
  • [26] A randomized, double-blind, single-dose study to evaluate the biosimilarity of QL1101 with bevacizumab in healthy male subjects
    Liu, Ya-nan
    Huang, Jie
    Guo, Can
    Yang, Shuang
    Ye, Ling
    Wu, Shu-ting
    Zhang, Xing-fei
    Yang, Xiao-yan
    Han, Cui-cui
    Pei, Qi
    Huang, Lu
    He, Qing-nan
    Yang, Guo-ping
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (03) : 555 - 562
  • [27] A phase I pharmacokinetics study comparing PF-06439535 (a potential biosimilar) with bevacizumab in healthy male volunteers
    Beverly Knight
    Danielle Rassam
    Shanmei Liao
    Reginald Ewesuedo
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 839 - 846
  • [28] A randomized pharmacokinetic/pharmacodynamic study comparing the bioequivalence of potential biosimilar candidate P044 with reference medicine in healthy volunteers
    Raykova, Ekaterina
    Farahani, Mohammad Farmahini
    Ivanova, Stanislava
    Azhdarzadeh, Morteza
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (02) : 235 - 243
  • [29] Single-dose pharmacokinetic study of ciprofloxacin and fleroxacin in healthy adult Nigerian volunteers
    Chukwuani, CM
    Coker, HAB
    Oduola, AMJ
    Ifudu, ND
    Sowunmi, A
    CHEMOTHERAPY, 1998, 44 (06) : 369 - 376
  • [30] Rectal and sublingual administration of tacrolimus: a single-dose pharmacokinetic study in healthy volunteers
    Stifft, Frank
    Vanmolkot, Floris
    Scheffers, Ingrid
    van Bortel, Luc
    Neef, Cees
    Christiaans, Maarten
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (05) : 996 - 1004
12345